Positron Emission Tomography (PET) studies rely on a specialized tracer to visualize metabolic activity within the body. This tracer, Fluorodeoxyglucose, is a modified sugar molecule that accumulates in areas of high metabolic function. By introducing FDG into the bloodstream and tracking its distribution through PET cameras, clinicians can detect